The CJC-1295 + Ipamorelin combination consists of two synthetic peptides in a single preparation, intended exclusively for laboratory research purposes. CJC-1295 is an analogue of growth hormone-releasing hormone (GHRH), acting via the GHRH receptors of the pituitary gland, while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist. Owing to the dual mechanism of action described in the literature, the two molecules are frequently used together in in vitro and preclinical studies to model the pulsatile activity of the somatotropic axis, receptor-level synergy and hormone secretion patterns.
Superhuman Laboratories offers this peptide combination in an automatic pen: the pre-set, click-based dosing system allows precise, reproducible amounts to be measured out, which is essential in research protocols for the consistency of dose-response curves. This solution eliminates the inaccuracies arising from the reconstitution of conventional lyophilised powders and repeated measurement with syringes, and also reduces the risk of contamination.
Every production batch undergoes HPLC and mass spectrometry analysis; peptide purity typically exceeds 99%, and the batch-specific certificate of analysis (CoA) is available upon request. It is recommended to store the preparation refrigerated (2–8 °C), protected from light, in its original packaging; shipping takes place under temperature-controlled conditions.
Important: this product is intended solely for laboratory research and in vitro use. It is not a medicinal product, not a food supplement and not a cosmetic product; it may not be used for human or animal consumption, nor for any diagnostic or therapeutic purpose. For qualified researchers only, in compliance with the applicable laboratory safety regulations.
Fast shipping — via GLS courier service within 1–3 business days, in thermally insulated packaging.
Discreet packaging — neither the product name nor its nature appears on the package.
Satisfaction guarantee — for unopened products, no questions asked.
